Development of transplant vasculopathy in aortic allografts correlates with neointimal smooth muscle cell proliferative capacity and fibrocyte frequency

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 393-402

  Onuta, Geanina ^a   van Ark, Joris ^a   Rienstra, Heleen ^a   Boer, Mark Walther ^a   Klatter, Flip A ^a   Bruggeman, Cathrien A ^b   Zeebregts, Clark J ^a   Rozing, Jan ^a   Hillebrands, Jan Luuk ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aorta; Fibrocyte; Neointima; Rat; Smooth muscle cell; Transplant vasculopathy; Transplantation

Indexed keywords

CD45 ANTIGEN; GELATINASE; MESSENGER RNA; NEUROPILIN; VIMENTIN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA GRAFT; AORTA INTIMA; ARTICLE; BLOOD VESSEL INJURY; CELL PROLIFERATION; CHIMERA; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MUSCLE CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIGENS, CD45; AORTA, ABDOMINAL; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; GRAFT REJECTION; MATRIX METALLOPROTEINASE 2; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, INBRED BN; RATS, INBRED LEW; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA; VIMENTIN;

EID: 77950022680     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.10.020     Document Type: Article

References (38)

1. Kouwenhoven E.A., IJzermans J.N., de Bruin R.W. Etiology and pathophysiology of chronic transplant dysfunction. Transpl Int 2000, 13:385-401.
2. Hayry P., Mennander A., Raisanen-Sokolowski A., et al. Pathophysiology of vascular wall changes in chronic allograft rejection. Transplant Rev 1993, 7:1-20.
3. Mitchell R.N., Libby P. Vascular remodeling in transplant vasculopathy. Circ Res 2007, 100:967-978.
4. Hutchinson I.V., Pravica V., Hajeer A., Sinnott P.J. Identification of high and low responders to allografts. Rev Immunogenet 1999, 1:323-333.
5. Aziz T., Hasleton P., Hann A.W., et al. Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation. J Thorac Cardiovasc Surg 2000, 119:700-708.
6. Densem C.G., Hutchinson I.V., Cooper A., Yonan N., Brooks N.H. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transplant 2000, 19:551-556.
7. Shahbazi M., Fryer A.A., Pravica V., et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002, 13:260-264.
8. Tambur A.R., Pamboukian S., Costanzo M.R., Heroux A. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy. J Heart Lung Transplant 2006, 25:690-698.
9. Hillebrands J.L., Klatter F.A., van den Hurk B.M., et al. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001, 107:1411-1422.
10. Hillebrands J.L., Onuta G., Rozing J. Role of progenitor cells in transplant arteriosclerosis. Trends Cardiovasc Med 2005, 15:1-8.
11. Lagaaij E.L., Cramer-Knijnenburg G.F., van Kemenade F.J., et al. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001, 357:33-37.
12. Hillebrands J., van den Hurk B.M., Klatter F.A., et al. Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis. J Heart Lung Transplant 2000, 19:1183-1192.
13. Bellini A., Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007, 87:858-870.
14. Hartlapp I., Abe R., Saeed R.W., et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 2001, 15:2215-2224.
15. Harmon K.J., Couper L.L., Lindner V. Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol 2000, 156:1741-1748.
16. Ibrahim J., Miyashiro J.K., Berk B.C. Shear stress is differentially regulated among inbred rat strains. Circ Res 2003, 92:1001-1009.
17. Coutard M., Osborne-Pellegrin M., Fontaine V., Jacob M.P., Michel J.B. High-flow-induced arterial remodeling in rats with different susceptibilities to cerebral aneurysms. J Vasc Res 2006, 43:217-228.
18. Assadnia S., Rapp J.P., Nestor A.L., et al. Strain differences in neointimal hyperplasia in the rat. Circ Res 1999, 84:1252-1257.
19. Nestor A.L., Cicila G.T., Karol S.E., et al. Linkage analysis of neointimal hyperplasia and vascular wall transformation after balloon angioplasty. Physiol Genomics 2006, 25:286-293.
20. Hylkema M.N., van der Deen M., Pater J.M., et al. Single expression of CD45RC and RT6 in correlation with T-helper 1 and T-helper 2 cytokine patterns in the rat. Cell Immunol 2000, 199:89-96.
21. Hillebrands J.L., Klatter F.A., Bruggeman C.A., Rozing J. Development of transplant arteriosclerosis after allogeneic aorta transplantation in the rat: influence of recipient genotype. Transplant Proc 2001, 33:324-325.
22. Valantine H.A. Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant " atheroma" Transplantation 2003, 76:891-899.
23. van Saase J.L., van der Woude F.J., Thorogood J., et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995, 59:1280-1285.
24. Geerling R.A., Ansari A.A., LaFond-Walker A.M., et al. Accelerated arteriosclerosis in aortic grafts: a role for cytokines in progressive intimal lesion development. Transplant Proc 1998, 30:946-947.
25. Baker J.E., Konorev E.A., Gross G.J., Chilian W.M., Jacob H.J. Resistance to myocardial ischemia in five rat strains: is there a genetic component of cardioprotection?. Am J Physiol Heart Circ Physiol 2000, 278:H1395-H1400.
26. Hillebrands J.L., Klatter F.A., van Dijk W.D., Rozing J. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 2002, 8:194-195.
27. Christie D.B., Kang J., Ashley D.W., et al. Accelerated migration and proliferation of smooth muscle cells cultured from neointima induced by a vena cava filter. Am Surg 2006, 72:491-496.
28. Myit S., Delafontaine P., Bochaton-Piallat M.L., et al. Different growth properties of neointimal and medial smooth muscle cells in response to growth factors. J Vasc Res 2003, 40:97-104.
29. Brisset A.C., Hao H., Camenzind E., et al. Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ Res 2007, 100:1055-1062.
30. Nykanen A.I., Krebs R., Tikkanen J.M., et al. Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation. Transplantation 2005, 79:182-189.
31. Sadeghi M.M., Esmailzadeh L., Zhang J., et al. ESDN is a marker of vascular remodeling and regulator of cell proliferation in graft arteriosclerosis. Am J Transplant 2007, 7:2098-2105.
32. Kobuke K., Furukawa Y., Sugai M., et al. ESDN, a novel neuropilin-like membrane protein cloned from vascular cells with the longest secretory signal sequence among eukaryotes, is up-regulated after vascular injury. J Biol Chem 2001, 276:34105-34114.
33. Guo X., Nie L., Esmailzadeh L., et al. Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination. J Biol Chem 2009, [published online August 19 2009 as manuscript M109.0496840].
34. Simper D., Stalboerger P.G., Panetta C.J., Wang S., Caplice N.M. Smooth muscle progenitor cells in human blood. Circulation 2002, 106:1199-1204.
35. Sugiyama S., Kugiyama K., Nakamura S., et al. Characterization of smooth muscle-like cells in circulating human peripheral blood. Atherosclerosis 2006, 187:351-362.
36. Metharom P., Liu C., Wang S., et al. Myeloid lineage of high proliferative potential human smooth muscle outgrowth cells circulating in blood and vasculogenic smooth muscle-like cells in vivo. Atherosclerosis 2008, 198:29-38.
37. Abe R., Donnelly S.C., Peng T., Bucala R., Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001, 166:7556-7562.
38. Varcoe R.L., Mikhail M., Guiffre A.K., et al. The role of the fibrocyte in intimal hyperplasia. J Thromb Haemost 2006, 4:1125-1133.